Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32846061

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2020 Aug 27
First author
Wirth LJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2020 Aug 27;383(9):868-869. doi: 10.1056/NEJMe2024831.
    note
    Source null
    related pmid
    32846067
    relationship
    Comment in

Authors and identifiers

  1. name
    Wirth LJ
    type
    Author
  2. name
    Sherman E
    type
    Author
  3. name
    Robinson B
    type
    Author
  4. name
    Solomon B
    type
    Author
  5. name
    Kang H
    type
    Author
  6. name
    Lorch J
    type
    Author
  7. name
    Worden F
    type
    Author
  8. name
    Brose M
    type
    Author
  9. name
    Patel J
    type
    Author
  10. name
    Leboulleux S
    type
    Author
  11. name
    Godbert Y
    type
    Author
  12. name
    Barlesi F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wirth LJ
    type
    Author
  2. name
    Sherman E
    type
    Author
  3. name
    Robinson B
    type
    Author
  4. name
    Solomon B
    type
    Author
  5. name
    Kang H
    type
    Author
  6. name
    Lorch J
    type
    Author
  7. name
    Worden F
    type
    Author
  8. name
    Brose M
    type
    Author
  9. name
    Patel J
    type
    Author
  10. name
    Leboulleux S
    type
    Author
  11. name
    Godbert Y
    type
    Author
  12. name
    Barlesi F
    type
    Author
bibliography ids
  1. nci-bib-a303e81054f61381b9330f1c
book metadata
content sha256
e6cb478672140219d74f3fa86d5c52f815382f15bd307fb6783bc18d3701a5c1
document type
citation
dois
  1. 10.1056/NEJMoa2005651
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32846061
immutable id
pubmed:32846061@e6cb478672140219d74f3fa86d5c52f815382f15bd307fb6783bc18d3701a5c1
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
9
name
The New England journal of medicine
nlm unique id
0255562
pages
825-835
volume
383
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2020 Aug 27;383(9):868-869. doi: 10.1056/NEJMe2024831.
    note
    Source null
    related pmid
    32846067
    relationship
    Comment in
outcomes validated
false
pmid
32846061
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
aa1cf72cce24635d69e5a0062631301d5c24914c2ccf04cd0f2d3d8745529d05
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Aug 27
precision
day
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32846061/
title
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.

Preserved source evidence · Not medical advice